Dendreon Corp fka DNDNQ

[Wolfeman]

Ranchero,
The first question at the AC was in regard to consistency of the manufactured product. Could this question have been in response to issues that the FDA inspection team reported? I agree that these CMC issues are a major management blunder by the BOD. But is it possible that they are minor and Gold said they'll be resolved by the end of the year simply because there is no rush. Also the FDA is obviously busy and a reinspection of a plant that is not fully operating is pretty far down on the list of priorities. It's my understanding that Provenge is being manufactured at the NJ plant. Do you know anything about this? Seems like an expensive building to operate for a few dozen doses of Provenge a month.

Can I just verify something? You are just participating in the lawsuit or did you start it?

BTW, I'm done with Investor Village for good and will be reading and posting here. Those idiots started today by writing mean spirited letters to Rob Stein, the guy who put the Provenge story on page 1 of the Washington Post. They can't even tell a friend from an enemy anymore. I wonder if all their efforts are actually hurting Provenge's chances rather then helping. After all the FDA would never want to seem to be caving to pressure from investors. Ha!

Thanks,
Wolfeman